Free Trial

Tenaya Therapeutics (TNYA) SEC Filings & 10K Form

Tenaya Therapeutics logo
$0.45 -0.01 (-2.58%)
Closing price 04/17/2025 04:00 PM Eastern
Extended Trading
$0.46 +0.01 (+2.44%)
As of 04/17/2025 06:19 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Tenaya Therapeutics SEC Filings

DateFilerForm TypeView
04/17/2025
3:05 PM
Tenaya Therapeutics (Filer)
Form DEF 14A
04/17/2025
3:08 PM
Tenaya Therapeutics (Filer)
Form DEFA14A
03/31/2025
11:15 PM
Tenaya Therapeutics (Filer)
Form EFFECT
03/10/2025
8:40 PM
Ali Faraz (Reporting)
Tenaya Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/10/2025
8:41 PM
Tenaya Therapeutics (Subject)
Tingley Whittemore (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/10/2025
8:42 PM
Ali Faraz (Reporting)
Tenaya Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
8:43 PM
Tenaya Therapeutics (Issuer)
Tingley Whittemore (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
8:44 PM
Higa Tomohiro (Reporting)
Tenaya Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
3:19 PM
Tenaya Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/07/2025
7:22 PM
Casdin Capital, LLC (Filed by)
Tenaya Therapeutics (Subject)
Form SCHEDULE 13D/A
03/07/2025
6:50 PM
COLUMN GROUP III, LP (Filed by)
Tenaya Therapeutics (Subject)
Form SCHEDULE 13D/A
03/07/2025
6:14 PM
GOEDDEL DAVID V (Reporting)
Tenaya Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
6:14 PM
COLUMN GROUP III GP, LP (Reporting)
COLUMN GROUP III, LP (Reporting)
COLUMN GROUP III-A, LP (Reporting)
Column Group Opportunity III GP, LP (Reporting)
Column Group Opportunity III, LP (Reporting)
TCG Opportunity III GP, LLC (Reporting)
Tenaya Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
9:52 AM
JPMORGAN CHASE & CO (Filed by)
JPMORGAN CHASE & CO (Filed by)
Tenaya Therapeutics (Subject)
Form SCHEDULE 13G/A
03/04/2025
3:28 PM
Tenaya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
5:42 PM
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Tenaya Therapeutics (Subject)
Form SCHEDULE 13G/A
02/10/2025
11:51 AM
JPMORGAN CHASE & CO (Filed by)
JPMORGAN CHASE & CO (Filed by)
Tenaya Therapeutics (Subject)
Form SCHEDULE 13G
02/07/2025
7:29 PM
Ali Faraz (Reporting)
Tenaya Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2025
7:30 PM
Higa Tomohiro (Reporting)
Tenaya Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/07/2025
3:58 PM
Tenaya Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/07/2025
3:41 PM
Tenaya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/05/2025
12:23 PM
BlackRock, Inc. (Filed by)
Tenaya Therapeutics (Subject)
Form SCHEDULE 13G/A
01/28/2025
7:00 PM
Tenaya Therapeutics (Issuer)
Tingley Whittemore (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/28/2025
4:12 PM
Tenaya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/17/2024
6:58 AM
Tenaya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/17/2024
6:24 AM
Tenaya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/18/2024
7:48 PM
Saito Chihiro (Reporting)
Tenaya Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
4:46 PM
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Tenaya Therapeutics (Subject)
Form SC 13G/A
11/06/2024
3:20 PM
Tenaya Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/21/2024
7:35 PM
Burroughs Amy L. (Reporting)
Tenaya Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/21/2024
7:37 PM
GOEDDEL DAVID V (Reporting)
Tenaya Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/21/2024
7:38 PM
Lee June (Reporting)
Tenaya Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/21/2024
7:39 PM
Parschauer Karah Herdman (Reporting)
Tenaya Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/21/2024
7:40 PM
Srivastava Deepak (Reporting)
Tenaya Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/21/2024
7:41 PM
Stehman-Breen Catherine (Reporting)
Tenaya Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/21/2024
7:42 PM
Tenaya Therapeutics (Issuer)
Williams R Sanders (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/21/2024
7:43 PM
Tenaya Therapeutics (Issuer)
Walsh Jeffrey T. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2024
5:26 AM
Tenaya Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/19/2024
7:30 PM
Saito Chihiro (Reporting)
Tenaya Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2024
7:23 PM
Saito Chihiro (Reporting)
Tenaya Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/16/2024
7:23 PM
Ali Faraz (Reporting)
Tenaya Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
Claim Your FREE Protection Guide (Ad)

In the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code... And since then, "in the know" patriots have quietly used this same "Trump loophole" to shield their life savings from the economic chaos. But with Trump now forcefully bringing back millions of manufacturing jobs from Mexico, China, and the entire BRICS anti-dollar coalition...

Click Here to Claim Your FREE Trump 100-Day Strategy Guide Now →
08/16/2024
7:24 PM
Tenaya Therapeutics (Subject)
Tingley Whittemore (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/16/2024
7:25 PM
Ali Faraz (Reporting)
Tenaya Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2024
7:26 PM
Tenaya Therapeutics (Issuer)
Tingley Whittemore (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2024
3:24 PM
Tenaya Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/25/2024
3:02 PM
Tenaya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/27/2024
4:10 PM
Tenaya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2024
3:15 PM
Tenaya Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/14/2024
3:09 PM
Tenaya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:TNYA) was last updated on 4/18/2025 by MarketBeat.com Staff
From Our Partners